Shanghai Pioneer Holding Ltd (HKG:1345)

Market Cap	2.53B
Revenue (ttm)	1.63B
Net Income (ttm)	161.35M
Shares Out	1.16B
EPS (ttm)	0.14
PE Ratio	15.73
Forward PE	n/a
Dividend	0.11 (5.17%)
Ex-Dividend Date	Jun 3, 2025

Volume	16,000
Average Volume	113,300
Open	2.210
Previous Close	2.200
Day's Range	2.150 - 2.210
52-Week Range	1.700 - 2.450
Beta	-0.06
RSI	51.38
Earnings Date	Aug 28, 2025

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, dental devices, and imported in...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 335
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1345

Financial Performance

In 2024, Shanghai Pioneer Holding's revenue was 1.53 billion, a decrease of -2.27% compared to the previous year's 1.57 billion. Earnings were 151.62 million, an increase of 9.46%.

Financial numbers in CNY